RCS - JPMorgan Asia G&I - Investor Webinar

Jpmorgan Asia Growth & IncomeAnnouncement

30/10/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251030:nRSd3922Fa&default-theme=true

RNS Number : 3922F  JPMorgan Asia Growth & Income PLC  30 October 2025

 

 LONDON STOCK EXCHANGE ANNOUNCEMENT

JPMORGAN ASIA GROWTH AND INCOME PLC

(the 'Company')

 

 

Legal Entity Identifier: 5493006R74BNJSJKCB17

 

Investor Webinar: 31(st) October 2025 11:00 a.m. BST

 

The Company is pleased to announce that Claire Peck, Emerging Markets &
Asia Pacific Investment Specialist, will be presenting on JPMorgan Asia Growth
& Income plc at the 'In the Hotseat Special: China vs India' tomorrow,
Friday, 31(st) October 2025 between 11a.m.

 

As a reminder JAGI takes an active, conviction-led approach focused on
providing total return from investing in equities quoted on the stock markets
of Asia, excluding Japan. The trust also allows investors to benefit from
regular quarterly dividends each equivalent to 1.5% of the NAV at the end of
each quarter.

The webinar is open to all existing and prospective shareholders. Registration
is free and can be accessed here
(https://quoteddata.com/events/in-the-hotseat-special-china-vs-india/) .  A
replay will also be made available to those who register.

 

 

For further information, please contact:

Investment Trust Sales

E-mail: Investment_trust_sales@jpmorgan.com

Tel: 0203 493 5904

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAFEUFWUEISEFS



            Copyright 2019 Regulatory News Service, all rights reserved